Acorah Software Products - Accounts Production 15.0.500 false true false true No description of principal activity 1 December 2022 30 November 2023 30 November 2023 14458586 Dr Besma Musaddaq iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14458586 2022-11-30 14458586 2023-11-30 14458586 2022-12-01 2023-11-30 14458586 frs-core:CurrentFinancialInstruments 2023-11-30 14458586 frs-bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 14458586 frs-bus:FilletedAccounts 2022-12-01 2023-11-30 14458586 frs-bus:Micro-entities 2022-12-01 2023-11-30 14458586 frs-bus:AuditExempt-NoAccountantsReport 2022-12-01 2023-11-30 14458586 frs-bus:Director1 2022-12-01 2023-11-30
Registered number: 14458586
Alpha Med Ltd
Unaudited Financial Statements
For The Year Ended 30 November 2023
Balance Sheet
Registered number: 14458586
2023
£
Fixed assets 675
Current assets 45,979
Creditors: Amounts Falling Due Within One Year (19,967 )
NET CURRENT ASSETS 26,012
TOTAL ASSETS LESS CURRENT LIABILITIES 26,687
Accruals and deferred income (630 )
NET ASSETS 26,057
CAPITAL AND RESERVES 26,057

Notes

1. General Information
Alpha Med Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14458586 . The registered office is 20 Beaufort Drive, London, NW11 6BU.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Dr Besma Musaddaq
Director
02/08/2024